Abstract

BackgroundInflammatory bowel disease (IBD) has an unknown etiology; however, accumulating evidence suggests that IBD is a multifactorial disease influenced by a combination of genetic and environmental factors. The influence of genetic variants on DNA methylation in cis and cis effects on expression have been demonstrated. We hypothesized that IBD susceptibility single-nucleotide polymorphisms (SNPs) regulate susceptibility gene expressions in cis by regulating DNA methylation around SNPs. For this, we determined cis-regulated allele-specific DNA methylation (ASM) around IBD susceptibility genes in CD4+ effector/memory T cells (Tem) in lamina propria mononuclear cells (LPMCs) in patients with IBD and examined the association between the ASM SNP genotype and neighboring susceptibility gene expressions.MethodsCD4+ effector/memory T cells (Tem) were isolated from LPMCs in 15 Japanese IBD patients (ten Crohn's disease [CD] and five ulcerative colitis [UC] patients). ASM analysis was performed by methylation-sensitive SNP array analysis. We defined ASM as a changing average relative allele score () >0.1 after digestion by methylation-sensitive restriction enzymes. Among SNPs showing >0.1, we extracted the probes located on tag-SNPs of 200 IBD susceptibility loci and around IBD susceptibility genes as candidate ASM SNPs. To validate ASM, bisulfite-pyrosequencing was performed. Transcriptome analysis was examined in 11 IBD patients (seven CD and four UC patients). The relation between rs36221701 genotype and neighboring gene expressions were analyzed.ResultsWe extracted six candidate ASM SNPs around IBD susceptibility genes. The top of (0.23) was rs1130368 located on HLA-DQB1. ASM around rs36221701 ( = 0.14) located near SMAD3 was validated using bisulfite pyrosequencing. The SMAD3 expression was significantly associated with the rs36221701 genotype (p = 0.016).ConclusionsWe confirmed the existence of cis-regulated ASM around IBD susceptibility genes and the association between ASM SNP (rs36221701) genotype and SMAD3 expression, a susceptibility gene for IBD. These results give us supporting evidence that DNA methylation mediates genetic effects on disease susceptibility.

Highlights

  • Crohn’s disease (CD) and ulcerative colitis (UC) are the two most common types of inflammatory bowel disease (IBD)

  • Among single-nucleotide polymorphisms (SNPs) showing DRAS>0.1, we extracted the probes located on tagSNPs of 200 Inflammatory bowel disease (IBD) susceptibility loci and around IBD susceptibility genes as candidate allele-specific DNA methylation (ASM) SNPs

  • We confirmed the existence of cis-regulated ASM around IBD susceptibility genes and the association between ASM SNP genotype and SMAD family member 3 (SMAD3) expression, a susceptibility gene for IBD

Read more

Summary

Introduction

Crohn’s disease (CD) and ulcerative colitis (UC) are the two most common types of inflammatory bowel disease (IBD). The etiology of IBD remains unknown, but accumulating evidence suggests that IBD is a multifactorial disease, influenced by a combination of genetic and environmental factors. Genome-wide association studies (GWAS) have associated more than 200 loci with IBD susceptibility [1,2,3,4,5]. These genetic susceptibility loci explain only a small proportion of disease heritability: 13.1% for CD and 8.2% for UC [3]. Inflammatory bowel disease (IBD) has an unknown etiology; accumulating evidence suggests that IBD is a multifactorial disease influenced by a combination of genetic and environmental factors. We determined cis-regulated allele-specific DNA methylation (ASM) around IBD susceptibility genes in CD4+ effector/memory T cells (Tem) in lamina propria mononuclear cells (LPMCs) in patients with IBD and examined the association between the ASM SNP genotype and neighboring susceptibility gene expressions

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call